Dr. Steven C. Napierkowski, MD

Dr. Napierkowski practices at Lone Star Heart And Vascular Center in Tomball, Texas.

Dr. Napierkowski's NPI, 1801143144, was assigned on August 6, 2012. Dr. Napierkowski graduated from McGovern Medical School at UTHealth in 2012. Dr. Napierkowski holds Texas license Q3248.

Dr. Napierkowski's primary practice is Lone Star Heart and Vascular Center, at 400 Holderrieth Blvd Suite 104 Suite 104, Tomball, TX 77375-1612. The practice phone is (281) 255-2000.

Dr. Napierkowski's primary practice is Lone Star Heart And Vascular Center in Tomball, Texas. Dr. Napierkowski is also affiliated with HCA Houston Healthcare Tomball. The medical group on file is Lone Star Heart & Vascular Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Napierkowski practices, 2 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Napierkowski's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Napierkowski is board certified in cardiovascular disease by the American Board of Internal Medicine. Dr. Napierkowski is licensed in Texas.

Dmand AI lists aneurysm, angioplasty, atrial fibrillation and flutter, cardiac catheterization, cardiomyopathy, cerebrovascular disease, chronic embolism thrombosis and chronic hypertension among the conditions Dr. Napierkowski treats.

CMS data shows 2,593 Medicare services from Dr. Napierkowski across 30 procedure codes in 2024, for 401 Medicare patients. Medicare paid $422,239 for them.

CMS counts 401 Medicare patients who saw Dr. Napierkowski in 2024. The largest group is 65 to 74, with 172 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Napierkowski's median patient age at 67, with 50% women.

In 2024, Dr. Napierkowski wrote 2,726 Medicare Part D claims for 359 patients. 85% of them were for generic drugs. CMS names the drug for 2,502 of them, across 38 drugs with 11 or more claims each, at $365,828 in total drug cost. In 2023, CMS named 2,103 claims across 34 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Napierkowski for performance year 2024, reported as part of a group. Dr. Napierkowski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 81 procedures of varicose vein removal by Dr. Napierkowski, more than 81% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Napierkowski in 2020. 2020 was the busiest year, with 4. Dr. Napierkowski's most frequent co-authors are Richard W. Smalling, MD, Abhijeet Dhoble, MD, MPH and Deepa Raghunathan.

CMS Open Payments shows 383 general payments to Dr. Napierkowski from 42 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 85% of the total. Boston Scientific Corporation paid the most, $3,384.

Dr. Napierkowski graduated from McGovern Medical School at UTHealth in 2012.

Dr. Napierkowski is in network with 22 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.